Australian regenerative medicine company Mesoblast faces a shareholder class action over disclosures related to its Remestemcel-L treatment for COVID-19 complications.
Ben Roberts-Smith flags ‘serious concerns’ about potential unlawful conduct by Fairfax
COVID-19 lease cancellation test case filed by Sydney bar
ACCC to fight production of JPMorgan witness statements in ANZ cartel case
The judge who vowed last year to move a criminal cartel case over a $2.5 billion ANZ share placement to trial “before we all retire” will soon weigh the ACCC’s claim for privilege over statements from JPMorgan witnesses it has been accused of pressuring during its investigation, two months after a different judge heard a still unresolved privilege fight in the long-running case.
Judge to decide if lockdown class action lawyer’s clients must hand over details
Creditors vote to place debt-laden Greensill in liquidation
AFR apologises to iSignThis as defamation case settles
Dentons adds HSF competition heavyweight to Sydney office
Nominate a young gun for Lawyerly’s Litigation Rising Stars 2021
‘Just tell us what we did wrong’: KPMG to get more details in Arrium class action
A judge has ordered the applicant in a shareholder class action against former Arrium directors and KPMG over allegedly misleading statements made ahead of Arrium’s $754 million capital raising in 2014 to explain how the amount by which the mining company’s assets were allegedly overvalued was calculated.